首页 / 院系成果 / 成果详情页

Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study (vol 10, 153, 2017)  期刊论文  

  • 编号:
    e383f63b-8171-4d19-b218-8e2bfad2b468
  • 作者:
    Liu, Xinyang[1,2];Qin, Shukui[3];Wang, Zhichao[2];Xu, Jianming[4];Xiong, Jianping[5];Bai, Yuxian[6];Wang, Zhehai[7];Yang, Yan[8];Sun, Guoping[9];Wang, Liwei[10];Zheng, Leizhen[11];Xu, Nong[12];Cheng, Ying[13];Guo, Weijian(郭伟剑)[14]Yu, Hao[15];Liu, Tianshu(刘天舒)[2]Lagiou, Pagona[1,16];Li, Jin[17];
  • 语种:
    英文
  • 期刊:
    JOURNAL OF HEMATOLOGY & ONCOLOGY ISSN:1756-8722 2018 年 11 卷 ; JAN 9
  • 收录:
  • 推荐引用方式
    GB/T 7714:
    Liu Xinyang,Qin Shukui,Wang Zhichao, et al. Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study (vol 10, 153, 2017) [J].JOURNAL OF HEMATOLOGY & ONCOLOGY,2018,11.
  • APA:
    Liu Xinyang,Qin Shukui,Wang Zhichao,Xu Jianming,&Li Jin.(2018).Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study (vol 10, 153, 2017) .JOURNAL OF HEMATOLOGY & ONCOLOGY,11.
  • MLA:
    Liu Xinyang, et al. "Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study (vol 10, 153, 2017)" .JOURNAL OF HEMATOLOGY & ONCOLOGY 11(2018).
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:20 下载次数:0
浏览次数:20
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部